IND

Related by string. in * * R Ind . SIMULATED TRADING PROGRAMS IN . REMAINS IN EFFECT UNTIL . #:# SUB IN . IN NO EVENT . IN ALL CAPS . CONTROL IN PROCURING COMPILING . CAUSED IN WHOLE OR . break ins . IN YOUR RECEIPT OF . INACCURACIES IN THE DOW . JONES CONTENT IN . YOU IN RELIANCE . GET KNOBIAS IN REAL . ALLOWED IN CHINA HONG . SIGN IN . IN TURBO WARRANTS REPRESENTS . FROM THOSE PROJECTED IN *

Related by context. Frequent words. (Click for all words.) 66 Investigational 64 New Drug IND 58 IND enabling 58 New Drug Application 54 NDA submission 53 Marketing Authorization Application 52 sNDA 52 pivotal Phase III 52 Phase III clinical 52 initiate Phase 52 Marketing Authorization Application MAA 52 preclinical 52 Phase Ib 51 Phase IIb 51 ANDAs 51 Phase IIa trial 51 investigational 51 Phase IIa 51 Marqibo 51 Phase IIb clinical 50 Phase 2b trial 50 Phase III trials 49 Phase III clinical trials 49 Phase IIb trial 48 investigational compound 48 clinical trials 48 Phase 2b clinical 48 Bronchitol 47 Phase IIa clinical 47 Phase 2a clinical 47 Phase III 47 Phase 2b study 47 vilazodone 47 sBLA 47 clinical 47 clinical trial 47 Phase 2b 47 AP# [003] 46 RDEA# 46 preclinical studies 46 Phase 2a 46 oral formulation 46 investigational drug 46 TREANDA 45 Orphan Drug Designation 45 confirmatory Phase 3 45 Phase III pivotal 45 orally administered 45 multiple ascending dose 45 AGENDA 44 Dyloject 44 recombinant human 44 MAA 44 oritavancin 44 Phase 1b 44 ADVEXIN 44 pivotal Phase 44 Mozobil 44 Iluvien 44 pandemic influenza vaccine 43 PF # [001] 43 ANDA 43 Phase II 43 HspE7 43 INCB# [002] 43 AEZS 43 therapeutics 43 PDUFA date 43 orphan drug 43 therapeutic antibody 43 clofarabine 43 NKTR 43 Clinical Trial 43 investigational oral 43 fidaxomicin 43 RNAi therapeutic 43 BLA 43 intravenous formulation 43 Drug Application 43 DAVANAT ® 43 APF# 43 ONCONASE 43 Surfaxin 43 GATTEX 42 voreloxin 42 humanized monoclonal antibody 42 ALKS 42 Preclinical studies 42 carfilzomib 42 IDX# 42 CUDC 42 YM BioSciences 42 indiplon 42 antisense drug 42 IMGN# 42 Antegren 42 resubmission 42 linaclotide 42 Sosei 41 Santhera 41 nimotuzumab

Back to home page